Skip to main content
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1986 Mar 15;134(6):609–610.

Hypoprothrombinemic hemorrhage due to cholestyramine therapy.

A M Shojania, D Grewar
PMCID: PMC1490907  PMID: 3948073

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Acuña R., González Ceron M. Hipoprotrombinemia y sindrome hemorragiparo asociado a tratamiento con colestiramina. Rev Med Chil. 1977 Jan;105(1):27–28. [PubMed] [Google Scholar]
  2. Casdorph H. R. Safe uses of cholestyramine. Ann Intern Med. 1970 May;72(5):759–759. doi: 10.7326/0003-4819-72-5-759. [DOI] [PubMed] [Google Scholar]
  3. Davies V. A., Rothberg A. D., Argent A. C., Atkinson P. M., Staub H., Pienaar N. L. Precursor prothrombin status in patients receiving anticonvulsant drugs. Lancet. 1985 Jan 19;1(8421):126–128. doi: 10.1016/s0140-6736(85)91901-4. [DOI] [PubMed] [Google Scholar]
  4. Gross L., Brotman M. Hypoprothrombinemia and hemorrhage associated with cholestyramine therapy. Ann Intern Med. 1970 Jan;72(1):95–96. doi: 10.7326/0003-4819-72-1-95. [DOI] [PubMed] [Google Scholar]
  5. Hofmann A. F., Poley J. R. Cholestyramine treatment of diarrhea associated with ileal resection. N Engl J Med. 1969 Aug 21;281(8):397–402. doi: 10.1056/NEJM196908212810801. [DOI] [PubMed] [Google Scholar]
  6. Mountain K. R., Hirsh J., Gallus A. S. Neonatal coagulation defect due to anticonvulsant drug treatment in pregnancy. Lancet. 1970 Feb 7;1(7641):265–268. doi: 10.1016/s0140-6736(70)90636-7. [DOI] [PubMed] [Google Scholar]
  7. Srinivasan G., Seeler R. A., Tiruvury A., Pildes R. S. Maternal anticonvulsant therapy and hemorrhagic disease of the newborn. Obstet Gynecol. 1982 Feb;59(2):250–252. [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES